SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Mobileye first quarter revenue falls by almost 50% as clients cut back on spending to clear excess stock

Melio names Boaz BenDavid as its first Chief Financial Officer

Check Point registers higher than expected Q1 profit helped by growth of AI-powered security platform

Microsoft explains how Generative AI impacts IP law and compliance

Buzz

Most popular

Daily

Weekly

1

Nvidia announces $700 million acquisition of Run:ai

2

Nvidia on verge of completing $700 million acquisition of Run:ai

3

Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale

4

Nvidia continues Israel shopping spree with acquisition of Deci

5

Nagomi Security raises $23 million Series A for proactive defense platform

Merck

4 stories about Merck

ד״ר צחון בנטואיץ׳ מייסד משותף של קיוריס Quris AI

Pharma giant Merck expands collaboration with Quris-AI

28.09.23|Meir Orbach

This follows the successful initial collaboration, a preclinical study to assess Quris-AI’s ability to predict drug toxicity in comparison to traditional in vitro and in vivo approaches

מוסף שבועי 18.5.23 פרופסור גל מרקל

Israeli biotech phenom puts death knell on cancer

21.05.23|Roni Dori

At 44, Gal Markel is a biotech bulldozer. After a $95 million exit, the professor of immunology serves as the Deputy Director General of Beilinson Hospital and the Director of the Davidoff Cancer Center, and is also involved in five startups. Now he has raised around $33 million to establish the Samueli Institute, researching ways to help the immune system eradicate cancer cells

“Pharma companies need to capitalize on early-stage breakthrough innovation.”

Collaboration is key for pharmaceutical companies as they seek to make the drug development process more efficient and successful, says Larisa Amir, managing director of Merck’s R&D Center.

Larisa Amir appointed Managing Director of Merck R&D Center in Israel

Amir will be responsible for managing the center and will also focus on in-house innovation and external scouting for technologies and biotechnology capabilities in Israeli startups, academia, and hospitals